Clinical Management of Epilepsy With Glutamic Acid Decarboxylase Antibody Positivity: The Interplay Between Immunotherapy and Anti-epileptic Drugs

Background: There is scanty guidance in the literature on the management of patients with glutamic acid decarboxylase (GAD65) antibody associated autoimmune epilepsy (GAD-epilepsy). GAD-epilepsy is a rare distinct neurological syndrome with a wide clinical spectrum. We describe six GAD-epilepsy pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Mäkelä, Kari-Matti, Hietaharju, Aki, Brander, Antti, Peltola, Jukka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053535/
https://www.ncbi.nlm.nih.gov/pubmed/30057567
http://dx.doi.org/10.3389/fneur.2018.00579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053535/
https://www.ncbi.nlm.nih.gov/pubmed/30057567
http://dx.doi.org/10.3389/fneur.2018.00579

Ejemplares similares